Thermo Fisher Scientific has entered a collaboration with Scinogy, specialists in closed, automated manufacturing systems for cell therapies, to develop and commercialize fit-for-purpose instrumentation and reagent systems aimed at improving productivity and scalability of cell and gene therapy manufacturing.   The manual processes commonly used in development and clinical trials are not cost-effective, transferable, or commercially viable. Alternative methods using more integrated systems often...